The advantages of SGLT2 inhibitors over DPP-4 inhibitors cannot be ascribed to differences in their antihyperglycemic effects, since in the large-scale trials, the two classes of drugs produced similar decreases in blood glucose during long-term treatment
Prescription drugs including Wegovy are exempt from the 3-1-1 liquids rule
More recently, interest has expanded to newer GLP-1 medications such as semaglutide and liraglutide
FDA Finalizes Guidance on Patient-Focused Drug Development (PFDD) The new PFDD guidance reinforces that clinical trials must capture what matters most to patients symptom burden, quality of life, daily functioning, and treatment tolerability
This skin-brightening supplement is highly recommended by doctors and healthcare providers, with simple to take daily with water
We invite you to join our webinar titled GLP-1 Drugs: Whats Next after FDAs Resolution of Drug Shortages on December 4, 2024 to learn more about these issues